ProfileGDS4718 / 1554628_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 86% 61% 88% 88% 83% 89% 87% 89% 86% 88% 90% 85% 86% 82% 78% 86% 82% 84% 68% 85% 86% 85% 90% 84% 90% 90% 75% 86% 85% 81% 79% 82% 91% 79% 80% 82% 81% 87% 60% 88% 88% 71% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.1619689
GSM549102patient 115, normal, homogenized [OPG study]8.4814386
GSM549104patient 119, normal, homogenized [OPG study]6.1944461
GSM549108patient 138, normal, homogenized [OPG study]8.8401688
GSM549119patient 077, normal, homogenized [OPG study]8.9252488
GSM549133patient 032, cancer, homogenized [OPG study]8.3279583
GSM549139patient 042, cancer, homogenized [OPG study]8.9817189
GSM549099patient 107, normal, homogenized [OPG study]8.7390987
GSM549109patient 139, normal, homogenized [OPG study]8.9908489
GSM549110patient 046, normal, homogenized [OPG study]8.642686
GSM549114patient 063, normal, homogenized [OPG study]9.0319588
GSM549122patient 082, normal, homogenized [OPG study]9.194990
GSM549134patient 033, cancer, homogenized [OPG study]8.4626785
GSM549136patient 036, cancer, homogenized [OPG study]8.617286
GSM549140patient 044, cancer, homogenized [OPG study]8.1253782
GSM549111patient 047, normal, homogenized [OPG study]7.6750578
GSM549113patient 057, normal, homogenized [OPG study]8.6938486
GSM549132patient 031, cancer, homogenized [OPG study]8.0414882
GSM549137patient 038, cancer, homogenized [OPG study]8.3361484
GSM549142patient 047, cancer, homogenized [OPG study]6.7081668
GSM549100patient 110, normal, homogenized [OPG study]8.4325485
GSM549107patient 135, normal, homogenized [OPG study]8.6219186
GSM549115patient 068, normal, homogenized [OPG study]8.6904285
GSM549116patient 072, normal, homogenized [OPG study]9.27190
GSM549120patient 078, normal, homogenized [OPG study]8.2851984
GSM549131patient 030, cancer, homogenized [OPG study]9.2068490
GSM549118patient 074, normal, homogenized [OPG study]9.2479690
GSM549129patient 027, cancer, homogenized [OPG study]7.4156175
GSM549123patient 088, normal, homogenized [OPG study]8.6288686
GSM549124patient 006, cancer, homogenized [OPG study]8.3473485
GSM549126patient 015, cancer, homogenized [OPG study]7.9214881
GSM549128patient 025, cancer, homogenized [OPG study]7.7919579
GSM549103patient 117, normal, homogenized [OPG study]7.9994882
GSM549117patient 073, normal, homogenized [OPG study]9.5328191
GSM549138patient 041, cancer, homogenized [OPG study]7.7749379
GSM549141patient 045, cancer, homogenized [OPG study]8.0022980
GSM549130patient 028, cancer, homogenized [OPG study]8.0007882
GSM549101patient 111, normal, homogenized [OPG study]7.9416481
GSM549105patient 128, normal, homogenized [OPG study]8.6391987
GSM549106patient 134, normal, homogenized [OPG study]6.1401260
GSM549112patient 048, normal, homogenized [OPG study]8.9203188
GSM549125patient 011, cancer, homogenized [OPG study]8.7738488
GSM549127patient 024, cancer, homogenized [OPG study]7.0845671
GSM549135patient 035, cancer, homogenized [OPG study]8.0034480